INITIATOR PHARMA

initiator-pharma-logo

Initiator Pharma is a Biotech company established in Aarhus, Denmark. Its main asset IPED2015 represents a novel treatment paradigm for the treatment of Erectile Dysfunction (ED) and will improve the quality of life for the growing number for patients (and their partners) that do not respond or cannot be treated with the current marketed medication.

#People #Website #More

INITIATOR PHARMA

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2016-01-01

Address:
Copenhagen, Hovedstaden, Denmark

Country:
Denmark

Website Url:
http://www.initiatorpharma.com

Total Employee:
1+

Status:
Active

Contact:
+45 6126 0035

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Apache


Current Employees Featured

ulf-simonsen_image

Ulf Simonsen
Ulf Simonsen Chief Scientific Officer & Co-Founder @ Initiator Pharma
Chief Scientific Officer & Co-Founder
2016-01-01

claus-elsborg-olesen_image

Claus Elsborg Olesen
Claus Elsborg Olesen Co-Founder & CEO @ Initiator Pharma
Co-Founder & CEO
2016-05-01

not_available_image

Dan Peters
Dan Peters Co-founder @ Initiator Pharma
Co-founder
2016-01-01

Founder


claus-elsborg-olesen_image

Claus Elsborg Olesen

not_available_image

Dan Peters

ulf-simonsen_image

Ulf Simonsen

Official Site Inspections

http://www.initiatorpharma.com

  • Host name: 104.18.1.98
  • IP address: 104.18.1.98
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Initiator Pharma"

Initiator Pharma - Crunchbase Company Profile & Funding

Initiator Pharma is a Biotech company. Initiator Pharma is a Biotech company established in Aarhus, Denmark. Its main asset IPED2015 represents a novel treatment paradigm for the …See details»

Management – Initiator Pharma

Born: 1963 Background: Ulf (MD., PhD) is trained as a medical doctor from Aarhus University and earned his PhD in physiology from Complutense University, Madrid, Spain in 1994.He became Professor of Pharmacology at …See details»

ANNUAL REPORT 2021 - Initiator Pharma

Telephone: +45 6126 0035 | Email: [email protected] TABLE OF CONTENTS “Although we have seen another year with an ongoing pandemic that to some extent has impacted our …See details»

Initiator Pharma - LinkedIn

Initiator Pharma | 742 followers on LinkedIn. Empowering Lives Through Meaningful Therapies | Initiator Pharma A/S, a clinical-stage pharma company developing innovative drugs targeting key unmet ...See details»

Initiator Pharma Company Description - Stock Analysis

4 days ago Company profile for Initiator Pharma A/S (STO: INIT) with a description, list of executives, contact details and other key facts.See details»

Initiator Pharma A/S - Drug pipelines, Patents, Clinical trials

Explore Initiator Pharma A/S with its drug pipeline, therapeutic area, technology platform, 10 clinical trials, and 2 literature, Disease Domain:Nervous System Diseases, Technology …See details»

Initiator Pharma - Overview, News & Similar companies - ZoomInfo

Oct 19, 2021 Initiator Pharma contact info: Phone number: +45 61260035 Website: www.initiatorpharma.com What does Initiator Pharma do? Initiator Pharma is a clinical-stage …See details»

Initiator Pharma A/S, INIT:STO profile - FT.com - Financial Times

Nov 19, 2024 Initiator Pharma A/S (INIT:STO) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»

Mission – Initiator Pharma

Vision. To become a leading life science company developing novel therapeutics within the field of CNS-disorders and diseases with significant unmet medical needs, for the benefit of both …See details»

Initiator Pharma - Craft

Initiator Pharma has 1 employees across 2 locations. See insights on Initiator Pharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

INITIATOR PHARMA: Q1 2023 REPORT - Placera

May 5, 2023 E-mail: [email protected]. About Initiator Pharma. Initiator Pharma A/S is a Danish clinical stage life science company developing innovative drugs that target key unmet …See details»

Initiator Pharma Company Profile 2024: Stock Performance

Initiator Pharma General Information Description. Initiator Pharma AS is a research and development company engaged in the pharmaceutical development of drugs to be used for …See details»

INITIATOR PHARMA: Q2 2022 REPORT

Aug 26, 2022 Claus Elsborg Olesen, CEO Telephone: +45 6126 0035 E-mail: [email protected]. About Initiator Pharma. Initiator Pharma A/S is a Danish clinical …See details»

Initiator Pharma A/S – Initiator Pharma

May 3, 2023 For more information, please visit www.initiatorpharma.com. Attachments. Initiator Pharma A/S Appendix 1 Initiator Pharma AS Draft Articles Of Association AGM 2023 Final …See details»

Initiator Pharma A/S (INIT.ST) - Yahoo Finance

Find the latest Initiator Pharma A/S (INIT.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»

PRESS RELEASE: Initiator Pharma reports ... - MAC Clinical Research

Dec 16, 2019 MAC Clinical Research is a full-service, global, pharmaceutical contract research organization (CRO), with science at the heart of everything we do. ... Further information: …See details»

INITIATOR PHARMA: YEAR END REPORT 2021

Business highlights in Q4 2021. Initiator Pharma A/S is a Danish clinical stage life science company developing innovative drugs that target key unmet medical needs within the central …See details»

Initiator Pharma A/S (Initiator Pharma A/S) - 药物管线_专利_临床 …

了解Initiator Pharma A/S (Initiator Pharma A/S)公司的药物管线,治疗领域,技术平台,以及它的10项临床试验和2篇文献,疾病领域:神经系统疾病,技术平台:小分子化药,药物:IP …See details»

INITIATOR PHARMA: Q1 2022 REPORT

Business highlights in Q1 2022 On January 20th the initiation of dosing in the IPTN2021 program Phase 1 to assess pain reducing effects in healthy...See details»